@article{Masanas_2021,
title={The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models},
volume={11},
ISSN={2001-1326},
url={http://dx.doi.org/10.1002/ctm2.533},
DOI={10.1002/ctm2.533},
number={10},
journal={Clinical and Translational Medicine},
publisher={Wiley},
author={Masanas,
Marc and Masiá,
Nuria and Suárez‐Cabrera,
Leticia and Olivan,
Mireia and Soriano,
Aroa and Majem,
Blanca and Devis‐Jauregui,
Laura and Burgos‐Panadero,
Rebeca and Jiménez,
Carlos and Rodriguez‐Sodupe,
Pau and Boloix,
Ariadna and Toledano,
Ignasi and Guillén,
Gabriela and Navarro,
Alexandra and Llobet‐Navas,
David and Villanueva,
Alberto and Sánchez de Toledo,
Josep and Roma,
Josep and Noguera,
Rosa and Moreno,
Lucas and Krauss,
Rolf and Gallego,
Soledad and Santamaria,
Anna and Segura,
Miguel F.},
year={2021},
month=oct }